Yale study finds costly breast cancer screenings don’t add up to better outcomes


Even though Medicare spends over $1 billion per year on breast cancer screenings such as a mammography, there is no evidence that higher spending benefits older women, researchers at Yale School of Medicine and the Yale Cancer Center found in a study published Online First by JAMA Internal Medicine, a JAMA Network publication.

Click here to read full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Yale Study Finds Costly Breast Cancer Screenings Don’t Add Up To Better Outcomes
Yale Study Finds Costly Breast Cancer Screenings Don’t Add Up To Better Outcomes
Yale Study Finds Costly Breast Cancer Screenings Don’t Add Up To Better Outcomes
Yale Study Finds Costly Breast Cancer Screenings Don’t Add Up To Better Outcomes

Yale Study Finds Costly Breast Cancer Screenings Don’t Add Up To Better Outcomes

More on: Health Medicine Network